clindamycin hydrochloride

Generic: clindamycin hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clindamycin hydrochloride
Generic Name clindamycin hydrochloride
Labeler a-s medication solutions
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

clindamycin hydrochloride 300 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-0967
Product ID 50090-0967_c72979ee-21bf-4363-974b-ee51898aeba7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA065061
Listing Expiration 2026-12-31
Marketing Start 2001-03-23

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] lincosamide antibacterial [epc] lincosamides [cs] neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500900967
Hyphenated Format 50090-0967

Supplemental Identifiers

RxCUI
284215
UNII
T20OQ1YN1W

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clindamycin hydrochloride (source: ndc)
Generic Name clindamycin hydrochloride (source: ndc)
Application Number ANDA065061 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (50090-0967-0)
  • 45 CAPSULE in 1 BOTTLE (50090-0967-1)
  • 16 CAPSULE in 1 BOTTLE (50090-0967-2)
  • 40 CAPSULE in 1 BOTTLE (50090-0967-3)
  • 20 CAPSULE in 1 BOTTLE (50090-0967-4)
source: ndc

Packages (5)

50090-0967-0 30 CAPSULE in 1 BOTTLE (50090-0967-0) 50090-0967-1 45 CAPSULE in 1 BOTTLE (50090-0967-1) 50090-0967-2 16 CAPSULE in 1 BOTTLE (50090-0967-2) 50090-0967-3 40 CAPSULE in 1 BOTTLE (50090-0967-3) 50090-0967-4 20 CAPSULE in 1 BOTTLE (50090-0967-4)

Ingredients (1)

clindamycin hydrochloride (300 mg/1)

Linked Drug Pages (1)

Clindamycin hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c72979ee-21bf-4363-974b-ee51898aeba7", "openfda": {"unii": ["T20OQ1YN1W"], "rxcui": ["284215"], "spl_set_id": ["22bf9385-cad3-43a7-802f-131b6826b5a5"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-0967-0)", "package_ndc": "50090-0967-0", "marketing_start_date": "20141128"}, {"sample": false, "description": "45 CAPSULE in 1 BOTTLE (50090-0967-1)", "package_ndc": "50090-0967-1", "marketing_start_date": "20141128"}, {"sample": false, "description": "16 CAPSULE in 1 BOTTLE (50090-0967-2)", "package_ndc": "50090-0967-2", "marketing_start_date": "20141128"}, {"sample": false, "description": "40 CAPSULE in 1 BOTTLE (50090-0967-3)", "package_ndc": "50090-0967-3", "marketing_start_date": "20141128"}, {"sample": false, "description": "20 CAPSULE in 1 BOTTLE (50090-0967-4)", "package_ndc": "50090-0967-4", "marketing_start_date": "20141128"}], "brand_name": "Clindamycin hydrochloride", "product_id": "50090-0967_c72979ee-21bf-4363-974b-ee51898aeba7", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "50090-0967", "generic_name": "Clindamycin hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clindamycin hydrochloride", "active_ingredients": [{"name": "CLINDAMYCIN HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA065061", "marketing_category": "ANDA", "marketing_start_date": "20010323", "listing_expiration_date": "20261231"}